Lazard Asset Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-145
Closed -$4K – 2522
2025
Q1
$4K Sell
145
-356
-71% -$12K ﹤0.01% 2186
2024
Q4
$19K Sell
501
-2,814
-85% -$109K ﹤0.01% 2075
2024
Q3
$128K Sell
3,315
-9,615
-74% -$389K ﹤0.01% 1718
2024
Q2
$543K Buy
12,930
+7,251
+128% +$247K ﹤0.01% 1171
2024
Q1
$166K Buy
5,679
+673
+13% +$21.5K ﹤0.01% 1369
2023
Q4
$181K Buy
5,006
+360
+8% +$11.8K ﹤0.01% 1425
2023
Q3
$149K Buy
+4,646
New +$158K ﹤0.01% 1484
2021
Q3
– Sell
-270
Closed -$14K – 2284
2021
Q2
$14K Buy
+270
New +$14.8K ﹤0.01% 1885
2020
Q4
– Sell
-1,542
Closed -$59K – 1976
2020
Q3
$59K Sell
1,542
-82
-5% -$3.6K ﹤0.01% 1136
2020
Q2
$70K Buy
1,624
+62
+4% +$2.35K ﹤0.01% 1122
2020
Q1
$52K Buy
1,562
+930
+147% +$33.6K ﹤0.01% 1162
2019
Q4
$26K Buy
632
+293
+86% +$12.3K ﹤0.01% 1183
2019
Q3
$15K Buy
+339
New +$14.8K ﹤0.01% 1159

Other funds holding SRDX

Lazard Asset Management's SRDX Position: Q2 2025 in Review

Lazard Asset Management sold out of Surmodics (SRDX) in Q2 2025, closing a stake of 145 shares — an estimated $4K sold.

Lazard Asset Management first reported a position in SRDX in Q3 2019 and held it in 13 quarters. The position peaked at $543K in Q2 2024. 135 funds tracked by Wall St. Rank hold SRDX as of Q2 2025.

  • Lazard Asset Management reported no remaining Surmodics position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 145 Surmodics shares in Q2 2025, an estimated $4K.
  • Lazard Asset Management first reported a position in Surmodics in Q3 2019 and held it in 13 quarters.
  • Lazard Asset Management's Surmodics position peaked at $543K in Q2 2024.
  • 135 funds tracked by Wall St. Rank held Surmodics as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.